Abstract
Patients with cystic fibrosis (CF) have increased risk of colorectal cancer (CRC). The utility of faecal occult blood testing (iFOBT) as a screening test is unclear. Colonoscopy is the current recommended CRC screening test in CF. This is a preliminary report of an ongoing study and aims to evaluate the role of iFOBT in adults with CF requiring CRC screening.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Paper Title
Journal
Date
